Skip to content

Clinical trials

Phase 3 Peripheral Arterial Disease trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Peripheral Arterial Disease Phase: Phase 3 Country / region: United States Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20071
20081
20093
20101
20112
20122
20131
20153
20172
20182
20192
20201
20212
20221
20231
20241
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Recruiting8
Active, not recruiting1
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Northwestern University6
Abbott Medical Devices2
Bayer2
Eli Lilly and Company2
AstraZeneca1
AtheroMed, Inc1
Boston Scientific Corporation1
CSL Behring1
Harvest Technologies1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Peripheral Arterial Disease31
Peripheral Vascular Diseases10
Atherosclerosis8
Intermittent Claudication6
Cardiovascular Diseases4
Chronic Limb-Threatening Ischemia3
Coronary Artery Disease3
Diabetes Mellitus, Type 23
Heart Diseases3
Stroke3

Trials

Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.